TRINALIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trinalin, and what generic alternatives are available?
Trinalin is a drug marketed by Schering and is included in one NDA.
The generic ingredient in TRINALIN is azatadine maleate; pseudoephedrine sulfate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate; pseudoephedrine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRINALIN?
- What are the global sales for TRINALIN?
- What is Average Wholesale Price for TRINALIN?
Summary for TRINALIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 49 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRINALIN at DailyMed |
US Patents and Regulatory Information for TRINALIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRINALIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRINALIN
See the table below for patents covering TRINALIN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 256109 | ⤷ Sign Up | |
| Japan | S4840356 | ⤷ Sign Up | |
| Italy | 1149233 | AZA DI BENZO-CICLO-EPTENI-5-SOSTITUITI E LORO PREPARAZIONE | ⤷ Sign Up |
| Switzerland | 538478 | Verfahren zur Herstellung von Aza-Dibenzo-Cyclohepten-5-on-Verbindungen und deren Verwendung zur Herstellung von Azo-Dibenzo-Cycloheptenen (Cpds. of general formulae I and II, and intermediates of general formula III where A = H or one or more of the following:- halogen, lower alkyl, -CF) | ⤷ Sign Up |
| Germany | 1695853 | 4-AZADIBENZOCYCLOHEPTENDERIVATE UND VERFAHREN ZU IHRER HERSTELLUNG | ⤷ Sign Up |
| Sweden | 349030 | ⤷ Sign Up | |
| Brazil | 6458580 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
